Skip to content
Screener

Cerus CERS Cash & Equivalents

Cash & Equivalents at other companies

Haemonetics logo
HaemoneticsHAE
$223.38M-23.7%
CorMedix logo
CorMedixCRMD
$179.08M+170%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$509M-2.7%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$420.08M+149%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$123.4M-18.7%
ADMA Biologics logo
ADMA BiologicsADMA
$136.02M+50.7%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$473.58M+119%
Enterprise value$490.69M+83.1%
P/S2.4×-0.8×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Cerus’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 5:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-197777
Line itemMarch 31, 2026December 31, 2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$27,850$19,961
Short-term investments52,57562,918
Accounts receivable, net29,32230,374
Current inventories61,12356,101
Prepaid and other current assets4,4715,030

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Cerus's cash & equivalents?
Cerus (CERS) reported cash & equivalents of $27.85M in Q1 2026.
How has Cerus's cash & equivalents changed year-over-year?
Cerus's cash & equivalents increased by 43.0% year-over-year, from $19.48M to $27.85M.
What is the long-term trend for Cerus's cash & equivalents?
Over 5 years (2020 to 2025), Cerus's cash & equivalents has grown at a -11.4% compound annual growth rate (CAGR), from $36.59M to $19.96M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Cerus's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude